These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 33844988)
41. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI). Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119 [TBL] [Abstract][Full Text] [Related]
42. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial. Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925 [TBL] [Abstract][Full Text] [Related]
43. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection. Mamo Y; Woodworth MH; Wang T; Dhere T; Kraft CS Clin Infect Dis; 2018 May; 66(11):1705-1711. PubMed ID: 29272401 [TBL] [Abstract][Full Text] [Related]
44. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota. McDonald JAK; Mullish BH; Pechlivanis A; Liu Z; Brignardello J; Kao D; Holmes E; Li JV; Clarke TB; Thursz MR; Marchesi JR Gastroenterology; 2018 Nov; 155(5):1495-1507.e15. PubMed ID: 30025704 [TBL] [Abstract][Full Text] [Related]
45. Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study. Samaey A; Vázquez-Castellanos JF; Caenepeel C; Evenepoel P; Vermeire S; Raes J; Knops N Pediatr Nephrol; 2024 Apr; 39(4):1201-1212. PubMed ID: 37775582 [TBL] [Abstract][Full Text] [Related]
46. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis. Hui W; Li T; Liu W; Zhou C; Gao F PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716 [TBL] [Abstract][Full Text] [Related]
48. Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study. Baunwall SMD; Hansen MM; Andreasen SE; Eriksen MK; Rågård N; Kelsen J; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL Aliment Pharmacol Ther; 2023 Sep; 58(5):503-515. PubMed ID: 37482926 [TBL] [Abstract][Full Text] [Related]
49. Functional profile of host microbiome indicates Nzabarushimana E; Tang H Gut Microbes; 2022; 14(1):2135963. PubMed ID: 36289064 [TBL] [Abstract][Full Text] [Related]
50. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease. Newman KM; Rank KM; Vaughn BP; Khoruts A Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756 [TBL] [Abstract][Full Text] [Related]
51. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease. Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592 [TBL] [Abstract][Full Text] [Related]
52. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388 [TBL] [Abstract][Full Text] [Related]
53. A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Rokkas T; Gisbert JP; Gasbarrini A; Hold GL; Tilg H; Malfertheiner P; Megraud F; O'Morain C United European Gastroenterol J; 2019 Oct; 7(8):1051-1063. PubMed ID: 31662862 [TBL] [Abstract][Full Text] [Related]
54. Fecal microbiota transplantation stimulates type 2 and tolerogenic immune responses in a mouse model. Moreau GB; Naz F; Petri WA Anaerobe; 2024 Apr; 86():102841. PubMed ID: 38521227 [TBL] [Abstract][Full Text] [Related]
55. Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon. Moura IB; Normington C; Ewin D; Clark E; Wilcox MH; Buckley AM; Chilton CH BMC Microbiol; 2020 Jan; 20(1):2. PubMed ID: 31898476 [TBL] [Abstract][Full Text] [Related]
56. Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota. Staley C; Vaughn BP; Graiziger CT; Singroy S; Hamilton MJ; Yao D; Chen C; Khoruts A; Sadowsky MJ Gut Microbes; 2017 May; 8(3):276-288. PubMed ID: 28282270 [TBL] [Abstract][Full Text] [Related]